Bitchute Telegram Feed

HPV Vaccines in China: What constitutes a Trade Secret?

Why did citizens of China have to petition their government for access to clinical trial data currently available via multiple national and international government sponsored internet sites? Why is information regarding HPV vaccines which is open for public view throughout most of the world deemed a ‘trade secret’ in China? These questions are particularly relevant when you consider the heated controversy surrounding HPV vaccination programs in so many countries around the world. Is it possible that Director Bi Jing-quan, leader of China’s State Bureau of Food & Drug Administration knows information contained in clinical trial data would reveal substantial safety concerns surrounding HPV vaccines? Does Director Bi Jing-quan think the citizens of China would be eager to use HPV vaccines if they knew the true rate of adverse events is not known because no inert placebos were used during clinical trials? Is that one of the reasons HPV vaccine clinical trial data is a ‘trade secret’ in China?

Read More

Dr. Sin Hang Lee recommends China postpone HPV vaccinations

China’s population consists of approximately 143 million females age 9-25. If human papillomavirus (HPV) vaccine manufacturers can convince the Chinese government to vaccinate every woman in this age group with 3 doses of HPV vaccine via a Publicly Funded Program as proposed by two of their paid consultants, the revenue generated could amount to over $64 billion USD (using price of HPV vaccines sold in the USA at $150/dose). This staggering amount of money would provide an enormous impact to their bottom line. But the question is at what cost?

Read More

Why Are Babies Dying in China After Receiving the Hepatitis B Vaccine?

At least nine babies have died in China the past few weeks after being injected with the Hepatitis B vaccine. The deaths, which have occurred within a very short time after receiving the vaccine, are gaining wide exposure in the China media. Because vaccines are almost always promoted as safe, injuries and deaths often are not associated with the vaccine, so there may be more deaths than have currently been reported. One of the deaths was reported by a family member after hearing about other babies dying shortly after receiving the vaccine in the media. When the family originally was fighting to save the baby from dying, they had not suspected the vaccine. Reaction in the media and the medical community in China is in stark contrast to how news like this is often reported in the U.S., where the mainstream media is reluctant to report any negative news regarding vaccines, and most doctors refuse to even acknowledge the risks vaccines carry. Here are some quotes from the China media: "Doctors also warn that the hepatitis B vaccine is not suitable for all newborns. Those suffering from fever, weak immune system, low birth weight or serious eczema should not be given the vaccination." "As the investigation continues, medical experts are reminding parents that infants don’t need to receive hepatitis B vaccines immediately after being born. They say it’s ok for parents to wait until the investigation results come out, before deciding whether they want to use the vaccines or not." In the U.S., one never reads any cautionary advice like this, in spite of the fact that deaths and serious adverse reactions do occur often.

Read More